20135 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR
#302Matrix mesalamine extended release minitablets and its process thereof
#303RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS
#304Medical devices and implements with liquid-impregnated surfaces
#305NONGRANULATED COMPRESSED TABLETS OF MESALAMINE, AND PROCESS OF PREPARATION THEREOF
#306SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH BREXPIPRAZOLE
#307SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH VORTIOXETINE
#308Treatment of Constipation-Predominant Irritable Bowel Syndrome
#309Compositions for treatment of attention deficit hyperactivity disorder
#310Compositions for Treatment of Attention Deficit Hyperactivity Disorder
#311CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#312Dietary nutrient compositions
#313SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH LURASIDONE
#314Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery
#315Self-righting systems, methods, and related components
#316Pharmaceutical composition comprising amniotic fluid stem cell spheroid and the use thereof in treatment of urinary incontinence
#317Enteric coated multiparticulate compositions with a proteinaceous subcoat
#318Skin Care Formulation for the Treatment of Acne
#319Sublingual Delivery for Mitigation of Side Effects Associated with Sildenafil Citrate
#320All-in-one fixed-dose combination for treating infection
#321Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating
#322Solid oral pharmaceutical composition
#323Modified release coated capsules
#324Low-Dose Stable Formulations of Linaclotide
#325A SUSTAINED RELEASE COMPOSITION COMPRISING A METHYLCELLULOSE
#326SOFT SHELL GELATIN CAPSULES INCORPORATING IMMEDIATE AND EXTENDED RELEASE DOSAGE FORMS AND METHODS OF MANUFACTURING
#327SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH BLONANSERIN
#328Once Daily Formulations Of Tetracyclines
#329Granular Pharmaceutical Composition
#330CAPSULE FORMULATION
#331SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH TRAZODONE
#332SUBLINGUAL DELIVERY FOR MITIGATION OF SIDE EFFECTS ASSOCIATED WITH OLANZAPINE AND METFORMIN
#333Drug delivery device
#334FORMULATIONS COMPRISING CYCLOSPORIN A
#335Inhalable powder formulations of alginate oligomers
#336Solid compositions of cocrystals of cannabinoids
#337LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#338Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and use
#339Method of using a rosemary extract composition for promoting a healthy body weight
#340Stabilized microcapsules, method of their preparation and uses thereof
#341Stabilized microcapsules, method of their preparation and uses thereof
#342Process for preparing a coated hard shell capsule
#343STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOF
#344COMPOSITION AND METHOD FOR THE TREATMENT OF COVID-19
#345Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#346NON-DIGESTIBLE CAPSULES FOR THE DELIVERY OF FLUID ABSORBING MATERIALS
#347Structured solid dosage form
#348STABILIZED FORMULATIONS OF CNS COMPOUNDS
#349Drug delivery device having controlled delivery and confirmation
#350Methods of treating multiple sclerosis
#351Enteric aerobization therapy
#352CANNABINOID COMPOSITION AND METHOD FOR TREATING PTSD AND/OR ANXIETY
#353COMPOSITION OF CARBON DIOXIDE ABSORBENT OR ADSORBENT, WHEREBY THE SAID COMPOSITION CONTAINS A POLYMERIC COATING SELECTED FROM SILICONE RUBBER AND CELLULOSE DERIVATIVE
#354FISETIN COMPOSITION AND A METHOD OF MAKING THE SAME
#355PHARMACEUTICAL COMPOSITION FOR AMELIORATION OF ADVERSE SIDE EFFECTS
#356Oligosaccharide formulations of kappa opioid receptor agonists
#357Composition and method of treating gastrointestinal disease with microbial and soy mixture
#358MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION, IMMEDIATE RELEASE PELLETS, SUSTAINED RELEASE PELLETS, ENTERIC RELEASE PELLETS AND USE THEREOF
#359SOLID SELF-EMULSIFYING PHARMACEUTICAL COMPOSITIONS
#360FORMULATIONS OF PIMAVANSERIN
#361Appetite suppressant compositions and methods thereof
#362PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#363Colon lavage system
#364COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#365PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER
#366Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#367SELF-EMULSIFYING SOLID ORAL DOSAGE FORMS OF ALLERGEN AND THEIR PREPARATION THEREOF
#368Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#369Pharmaceutical formulation of odevixibat
#370Method for treating coronavirus infections
#371Formulation for pain management
#372Coaxial nozzle configuration and methods thereof
#373Microbiome protection from oral antibiotics
#374CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#375Fumarate ester dosage forms with enhanced gastrointestinal tolerability
#376ACID RESISTANT CAPSULES
#377ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE
#378Capsule device for delivery of active agent to gastrointestinal tract
#379COMPOSITIONS, USES AND METHODS FOR TREATMENT AND/OR PREVENTION OF ELEVATED CHOLESTEROL, HYPERCHOLESTEROLEMIA, AND CARDIOVASCULAR DISEASE
#380Formulation for pain management
#381METHOD AND ENCAPSULATED SUBSTANCE FOR TREATING PAIN DUE TO A VARIETY OF DISEASES
#382Methods for manufacturing capsules with ingestible event markers
#383CANNABINOID COATED NANO-CAPSULES
#384Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device
#385SYSTEMS FOR ENTERIC DELIVERY OF THERAPEUTIC AGENTS
#386Pharmaceutical composition of Tamsulosin and Dutasteride
#387Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#388Granular Pharmaceutical Composition
#389Fumarate ester dosage forms
#390Delivery Capsule with Threshold Release
#391Self-righting articles
#392FORMULATIONS FOR A TIGHT JUNCTION EFFECTOR
#393SOLID FORMS AND FORMULATIONS COMPRISING A GLUCOCORTICOID RECEPTOR ANTAGONIST AND USES THEREOF
#394Apixaban formulations
#395COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE
#396PHARMACEUTICAL COMPOSITIONS
#397ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF
#398Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#399Microbiota restoration therapy (MRT) compositions and methods of manufacture
#400Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
#401CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY
#402Plant soft capsule and preparation method and application thereof
#403Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#404Dosage forms of controlled release at specific gastrointestinal sites
#405Capsule filling composition, method of producing capsule formulation with the use of capsule filling composition, and capsule formulation
#406Orally ingestible delivery system
#407Compositions and methods for treating centrally mediated nausea and vomiting
#408Compositions for treatment of attention deficit hyperactivity disorder
#409Crystalline particles of bis-choline tetrathiomolybdate
#410METHOD OF BOWEL PREPARATION FOR COLONOSCOPY
#411Oral use of coriander seed oil for a soothing effect on reactive skin
#412CONTROLLED RELEASE ORAL PHARMACEUTICAL DOSAGE FORMS COMPRISING MGBG
#413Pharmaceutical formulation
#414Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#415DOSAGE FORMS WITH DESIRED RELEASE PROFILES AND METHODS OF DESIGNING AND MAKING THEREOF
#416Methods and compositions for treating diabetes
#417FORMULATIONS OF PIMAVANSERIN
#418Compositions for treatment of attention deficit hyperactivity disorder
#419A METHOD INDUCING SATIETY IN A MAMMAL
#420COMPOSITIONS COMPRISING CO-SELECTED MICROBIOTA AND METHODS FOR USE THEREOF
#421Oral cannabinoid compositions and methods for treating neuropathic pain
#422Ingestible device with pharmaceutical product
#423Opioid overdose rescue device
#424MODIFIED RELEASE COMPOSITION COMPRISING A CANNABINOID
#425Capsules with opacifier
#426PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS
#427Preparation comprising exanatide for delivery into a lumen of the intestinal tract
#428COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING SAME
#429COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE
#430Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
#431Crystal modifications of odevixibat
#432PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF
#433Methods of treating multiple sclerosis
#434TREATMENT OF IRRITABLE BOWEL AND INFLAMMATORY BOWEL DISEASE
#435Probiotic Delivery Systems
#436Beta-lactamase formulations and uses thereof
#437IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
#438Pharmaceutical formulation of palbociclib and a preparation method thereof
#439Polyherbal composition for preventing and alleviating polycystic ovary syndrome
#440COMPOSITIONS COMPRISING CO-CRYSTALS OF STILBENOIDS AND CANNABINOIDS
#441Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
#442Pharmaceutical dosage form for application to mucous membranes
#443Drug-containing capsule, and component for air treatment device
#444PROCEDURE FOR PREPARING ENTERIC-COATED PELLETS CONTAINING A PROTON PUMP INHIBITOR AND MULTI-PARTICLE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#445Compositions and methods for treating eosinophilic disorders
#446Self-righting systems, methods, and related components
#447Oral delivery of therapeutic mammalian cells
#448SOFT DUAL CHAMBERED LIQUID-GEL CAPSULE AND METHOD TO DELIVER SUBLINGUAL AND INGESTIBLE CANNABIS COMPOSITIONS
#449Self-emulsifying cannabidiol formulations
#450ABUSE-DETERRENT DRUG FORMULATIONS
#451Methods of treating multiple sclerosis
#452TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#453Enterically coated cysteamine, cystamine and derivatives thereof
#454PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER
#455Implantable medical devices for extended release of therapeutic agents
#456Components with high API loading
#457Oral delivery of GLP-1 peptide analogs
#458Anti-methanogenic compositions and uses thereof
#459TREATMENT OF INFLAMMATORY DISEASE USING INGESTIBLE DEVICE TO RELEASE IMMUNE MODULATOR
#460Medication Delivery Device and Method
#461ABIRATERONE ACETATE LIPID FORMULATIONS
#462Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#463Tissue anchoring articles
#464METHOD FOR PRODUCING A PHARMACEUTICAL CARRIER
#465Ingestible medical delivery devices
#466Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#467Expandable drug delivery pill
#468Stable solutions of multicyclic antidepressants
#469Device, system and methods for the oral delivery of therapeutic compounds
#470COMPLEX WITH CORE-SHELL STRUCTURE AND APPLICATIONS THEREOF
#471Compounds to modulate intestinal absorption of nutrients
#472Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#473TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#474FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL
#475TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#476METHOD FOR TREATING TRAUMATIC BRAIN INJURY
#477COMBINATIONS FOR THE TREATMENT OF KIDNEY STONES
#478PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
#479Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#480TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH
#481Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#482COMPOSITIONS AND METHODS FOR THE TREATMENT OF CONSTIPATION AND OTHER AILMENTS OF THE GASTROINTESTINAL SYSTEM
#483PHARMACEUTICAL CARRIER DESIGN
#484Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
#485COMPOSITIONS COMPRISING BACTERIAL STRAINS
#486Method of administering amantadine prior to a sleep period
#487PHARMACEUTICAL COMPOSITIONS
#488PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY
#489SOLID PREPARATION OF CARIPRAZINE FOR ORAL ADMINISTRATION
#490PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#491Compositions and methods for treating beta-globinopathies
#492Total flavonoid extract from Kitam., preparation method thereof, and use of same in treating non-alcoholic fatty liver disease
#493ABUSE-PROOFED DOSAGE FORM
#494Granular Pharmaceutical Composition
#495HOMOGENEOUS POLYSACCHARIDE ESP-B4, DERIVED FROM HERBA EPHEDRA, PREPARATION METHOD AND MEDICAL USE THEREOF
#496PHARMACEUTICAL COMPOSITIONS
#497THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#498Treatment of a disease of the gastrointestinal tract with a SMAD7 inhibitor
#499Fast-acting plant-based medicinal compounds and nutritional supplements
#500Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
#501NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITOR
#502Compositions for treatment of attention deficit hyperactivity disorder
#503Compositions for treatment of attention deficit hyperactivity disorder
#504ARTICLES OF MANUFACTURE AND METHODS OF TREATMENT FOR ANEMIA
#505LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#506COMPOSITION COMPRISING AN ORGANIC LIQUID DILUENT AND A SPECIFIC HYDROXYALKYL METHYLCELLULOSE
#507STABLE CAPSULES WITH FECAL MICROBIOTA OR A CULTURE OF MICROORGANISMS
#508Colon lavage system
#509METHODS OF USE FOR OENOTHEIN A AND B FROM EPILOBIUM SPECIES
#510PHARMACEUTICAL COMPOSITIONS
#511USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA
#512MANGANOPORPHYRIN-POLYPHENOL MULTILAYER CAPSULES AS RADICAL AND REACTIVE OXYGEN SPECIES SCAVENGERS
#513Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates
#514Authentication of medication delivery vehicle to facilitate medication release
#515Swallowable drug delivery device and methods of drug delivery
#516Compositions and methods for the treatment and prevention of cognitive decline and preservation of neuronal function
#517CAPSULE FORMULATIONS
#518Oral Medicine Delivery Capsule
#519Xanthohumol-based compositions
#520Self-righting systems and related components and methods
#521Milrinone controlled-release formulation
#522Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#523Preparation comprising exanatide for delivery into a lumen of the intestinal tract
#524HYDROXYCITRIC ACID COMPOUNDS AND CAPSULE LIQUID DELIVERY
#525Biguanide compositions and methods of treating metabolic disorders
#526Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
#527Pharmaceutical formulation containing gelling agent
#528PHARMACEUTICAL COMPOSITIONS
#529ADMINISTRATION OF BUTYRATE, BETA-HYDROXYBUTYRATE, CANNABIDIOL, AND RELATED COMPOUNDS IN HUMANS
#530Self-righting systems and related components and methods
#531Pharmaceutical compositions for delivery of peptide
#532METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA
#533Extended relief dosage form
#534Compositions for treating addiction
#535Method of treating heart failure with preserved ejection fraction by administering milrinone
#536Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#537Composition and method of extract for weight management
#538ABUSE-DETERRENT DRUG FORMULATIONS
#539Method of using a rosemary extract composition for weight management
#540PHARMACEUTICAL COMPOSITIONS FOR TREATING ACNE
#541LIPOSOMAL ENCAPSULATION METHOD AND DEVICES
#542Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#543Pharmaceutical composition comprising PDE9 inhibitor
#544HIGH-SPEED SOFT CAPSULE FORMING MACHINE
#545PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#546CANNABINOID AND MENTHOL GUM AND LOZENGE COMPOSITIONS AND METHODS
#547Timed, pulsatile release systems
#548Multiple-fill/chamber softgel die
#549Treating pain in patients with hepatic impairment
#550Pharmaceutical compositions and uses thereof
#551Use of NK-1 receptor antagonists in pruritus
#552Expandable pill
#553Oral cholestyramine formulation and use thereof
#554Oral cholestyramine formulation and use thereof
#555Controlled release capsule
#556Low-Dose Stable Formulations of Linaclotide
#557COMPOSITION COMPRISING FECAL MICROBIOTA
#558Butyrate salts for use in inflammatory diseases
#559TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#560Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
#561ABUSE-PROOFED ORAL DOSAGE FORM
#562Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#563TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#564Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#565Miniature ingestible device
#566Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#567ORAL PHARMACEUTICAL DOSAGE FORMS
#568Cromolyn derivatives and related methods of imaging and treatment
#569Method to improve the health of the microbiome in a human gastrointestinal system and multi-chamber probiotic delivery products therefor
#570Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor
#571Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#572Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
#573Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#574Compositions and methods for promoting a healthy microbial flora in a mammal
#575Pharmaceutical formulation of palbociclib and a preparation method thereof
#576Pharmaceutical formulation of palbociclib and a preparation method thereof
#577PHARMACEUTICAL COMPOSITION AND METHOD FOR ACUTE ON CHRONIC LIVER FAILURE AND RELATED LIVER DISEASES
#578Multiple Sclerosis Treatment Regimen Using Dimethyl Fumarate
#579Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine Hydrochloride
#580Methods and Compositions for Treating Diabetes
#581APPARATUS AND PROCESS FOR ENCAPSULATING CAPSULES OR OTHER SOLID DOSAGE FORMS WITHIN CAPSULES
#582PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#583Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#584Coating of Nanoparticle Surfaces with Cyclopeptides for Improving Delivery of Agents Via the Oral Route
#585Tamper resistant oral opioid agonist formulations
#586LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#587Controlled release pharmaceutical compositions comprising a fumaric acid ester
#588Hard Capsule Shell Compositions for the Oral Contraceptive Formulations
#589Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications
#590Rifabutin-based compositions and methods for treating infection
#591Anti-methanogenic compositions and uses thereof
#592COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE
#593PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER
#594ABUSE-PROOFED DOSAGE FORM
#595Controlled release pharmaceutical formulations of nitazoxanide
#596Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse
#597Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#598COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS
#599Method of making an L-menthol dosage form
#600Dual release dosage form capsule and methods, devices and systems for making same